Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q35198070)
Watch
English
Prevention and treatment of motor fluctuations
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12915071
retrieved
7 August 2017
review article
1 reference
stated in
Europe PubMed Central
title
Prevention and treatment of motor fluctuations
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12915071
retrieved
7 August 2017
author
Fabrizio Stocchi
object named as
Fabrizio Stocchi
series ordinal
1
0 references
publication date
1 August 2003
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12915071
retrieved
7 August 2017
published in
Parkinsonism and Related Disorders
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12915071
retrieved
7 August 2017
volume
9 Suppl 2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12915071
retrieved
7 August 2017
page(s)
S73-81
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12915071
retrieved
7 August 2017
cites work
An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Levodopa: why the controversy?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment interventions for Parkinson's disease: an evidence based assessment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Emerging therapies in the pharmacological treatment of Parkinson's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Success and problems of long-term levodopa therapy in Parkinson's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Parkinson's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Episodic unresponsiveness to single doses of L-dopa in parkinsonian fluctuators
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Young onset Parkinson's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
"On-off" effects in patients with Parkinson's disease on chronic levodopa therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Levodopa pharmacokinetic mechanisms and motor fluctuations in Parkinson's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, Part I
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, Part II.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Wearing-off fluctuations in Parkinson's disease: contribution of postsynaptic mechanisms.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Motor response to apomorphine and levodopa in asymmetric Parkinson's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Levodopa-induced dyskinesia: review, observations, and speculations
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The Long-Duration Action of Levodopa May Be Due to a Postsynaptic Effect
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-duration effect and the postsynaptic compartment: study using a dopamine agonist with a short half-life.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pathophysiology of the basal ganglia in Parkinson's disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Continuous dopamine-receptor stimulation in early Parkinson's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmoset
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with L-DOPA therapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cabergoline in the treatment of early Parkinson's disease: results of the first year of treatment in a double-blind comparison of cabergoline and levodopa. The PKDS009 Collaborative Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pergolide monotherapy in the treatment of early PD: a randomized, controlled study. Pergolide Monotherapy Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacodynamic and Pharmacokinetic Features of Cabergoline
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dopamine agonists in the treatment of Parkinson s disease past, present and future
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of cabergoline in long-term use: results of three observational studies in 1,500 patients with Parkinson's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Influence of meal ingestion time on pharmacokinetics of orally administered levodopa in parkinsonian patients.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gastrointestinal dysfunction in Parkinson's disease: frequency and pathophysiology
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term duodenal infusion of levodopa for motor fluctuations in parkinsonism
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Duodenal delivery of levodopa for on-off fluctuations in parkinsonism: preliminary observations.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of L-[18F]fluorodopa uptake into human brain by amino acids demonstrated by positron emission tomography
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Double-blind, placebo-controlled, crossover study of duodenal infusion of levodopa/carbidopa in Parkinson's disease patients with 'on-off' fluctuations.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Fluctuating parkinsonism: a pilot study of single afternoon dose of levodopa methyl ester
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The Clinical Efficacy of Single Morning Doses of Levodopa Methyl Ester
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and safety of entacapone in Parkinson's disease patients with suboptimal levodopa response: a 6-month randomized placebo-controlled double-blind study in Germany and Austria (Celomen study).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and tolerability of entacapone as adjunctive therapy to levodopa in patients with Parkinson's disease and end-of-dose deterioration in daily medical practice: an open, multicenter study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized, placebo-controlled study of tolcapone in patients with fluctuating Parkinson disease treated with levodopa-carbidopa. Tolcapone Fluctuator Study Group III.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Q64871851
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetic-pharmacodynamic relationship of levodopa with and without tolcapone in patients with Parkinson's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of peripheral catechol-O-methyltransferase inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of entacapone, a COMT inhibitor, on clinical disability and levodopa metabolism in parkinsonian patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tolcapone and hepatotoxic effects. Tasmar Advisory Panel
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tolcapone and fulminant hepatitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neuroleptic malignant-like syndrome and acute hepatitis during tolcapone and clozapine medication
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pergolide. A review of its pharmacological properties and therapeutic potential in Parkinson's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Controlled study of the antiparkinsonian activity and tolerability of cabergoline
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Beneficial effect of cabergoline, new long-lasting D2 agonist in the treatment of Parkinson's disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: A 6-month interim report of a 3-year study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease. International Pramipexole-Bromocriptine Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pergolide in the treatment of Parkinson's disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
THERAPEUTIC EFFICACY OF APOMORPHINE COMBINED WITH AN EXTRACEREBRAL INHIBITOR OF DOPAMINE RECEPTORS IN PARKINSON'S DISEASE
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Subcutaneous apomorphine in the treatment of Parkinson's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Subcutaneous apomorphine in Parkinson's disease: response to chronic administration for up to five years
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Transient cardiac arrest during continuous intravenous infusion of apomorphine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sustained cabergoline treatment reverses levodopa-induced dyskinesias in parkinsonian monkeys
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Subcutaneous lisuride infusion in Parkinson's disease. Response to chronic administration in 34 patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
SUBCUTANEOUS APOMORPHINE IN PARKINSONIAN ON-OFF OSCILLATIONS
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Subcutaneous apomorphine in late stage Parkinson's disease: a long term follow up.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term intraduodenal infusion of a water based levodopa-carbidopa dispersion in very advanced Parkinson's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Implantable venous access system for apomorphine infusion in complicated Parkinson's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900021-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1353-8020(03)00021-X
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12915071
retrieved
7 August 2017
PubMed publication ID
12915071
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12915071
retrieved
7 August 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit